Abstract -A sesquiterpene was purified from Artemisia iwayomogi methanolic extract during the course of searching anti-inflammatory principle from medicinal plants. A sesquiterpene identified as armefolin inhibited the production of nitric oxide (NO) and attenuated inducible nitric oxide synthase (iNOS) protein level in lipopolysaccharide (LPS)-activated RAW 264.7 cells. Armefolin also down-regulated mRNA expressions of iNOS and pro-inflammatory cytokines, interleukin-1β and interleukin-6 in LPS-activated macrophages. Moreover, armefolin suppressed the degradation of inhibitory-κBα (I-κBα) in LPS-activated macrophages. These data suggest that armefolin from A. iwayomogi can suppress the LPS-induced production of NO and the expression of iNOS gene through inhibiting the degradation of I-κBα. Taken together, armefolin from A. iwayomogi might be a candidate as promising anti-inflammatory agent.
Inhibitory Effect of a Sesquiterpene from Artemisia iwayomogi on Expression of Inducible Nitric Oxide Synthase by Suppression of I-κBα Degradation in LPS-stimulated RAW 264.7 Cells
Introduction
Artemisia iwayomogi Kitamura (Compositae) is a perennial plant that is widely distributed throughout Korea. The aerial parts of this plant have been used as traditional herbal medicine for treating various diseases.
1
A. iwayomogi has been exhibited the cytoprotective activty on oxidative damaged cells and anti-atoptic dermatitis activity. 2, 3 Aqueous extract of A. iwayomogi attenuats cholestatic liver fibrosis in rat model. 4 In addition, essential oil of A. iwayomogi shows the antibacterial activity.
5 Genkwanin (flavonoid) and scopoletin (coumarin) from A. iwayomogi scavenged peroxynitrite, a potent cytotoxic oxidant formed by the reaction of nitric oxide (NO) with superoxide radical. 6 We previously reported two sesquiterpenes from A. iwayomogi that suppressed NO production by down-regulated inducible nitric oxide synthase (iNOS) expression. 7 Nitric oxide (NO), an unstable free radical and inflammatory mediator, is synthesized from L-arginine by nitric oxide synthase (NOS). Constitutive NOS (cNOS) produces low concentration of NO which plays an important role in the regulation of blood pressure and neurotransmission in normal condition. However, a large amounts of NO was produced by inducible NOS (iNOS) in inflammatory conditions. 8 High levels of NO and iNOS expression were found in various inflammatory diseases such as cardiovascular disease, cancer, rheumatoid arthritis, neurological disease, and metabolic disorder. [9] [10] [11] [12] Furthermore, it has been suggested that overproduction of NO provokes the pathogenesis of various inflammatory processes 13, 14 and plays role in carcinogenic process in vivo. 15, 16 Therefore, regulation of inflammatory response by inhibition of NO overproduction or iNOS expression could be therapeutic strategy for inflammatory diseases.
In present study, a sesquiterpene from A. iwayomogi was isolated as an inhibitor of NO production in LPSstimulated macrophages. We examined the effects of this active sesquiterpene on the expressions of iNOS and proinflammatory cytokines and revealed the possible molecular mechanism for these responses.
Experimental
General experimental procedures − Mass spectrum was obtained on a JEOL JMS-700 mass spectrometer. NMR spectra were recorded on a Varian UNITY INOVA 400 NMR spectrometer. Column chromatography was carried out over silica gel (40 -60 μm, Merk) and HPLC was performed on μ-Bondapak C 18 column (5 μm, 3.9 × 300 mm, Waters Co., Milford, MA, USA Extraction and isolation − The methanolic extract (183 g) of the air-dried A. iwayomogi (1.3 kg) was suspended in water and extracted with diethyl ether to give an ether soluble layer (40 g). The ether soluble layer was subjected to silica gel column chromatography using CHCl 3 /MeOH gradient system (100:1 to 1:1, v/v) to give 10 fractions (Fr.1-Fr.10). Fr.6 (2 g) was further silica gel chromatographed using n-Hexane/EtOAc (20:1, v/v) and semipreparative HPLC with 20% aqueous acetonitrile to yield 1 (6 mg). The structure of compound 1 was identified as armefolin ( Fig Cell culture − RAW 264.7 cells (a murine macrophage cell line, ATCC, Rockville, MD, USA) were cultured in DMEM medium containing 10% FBS, 100 units/mL penicillin, and 100 μg/mL streptomycin (Life Technologies, Frederick, MD, USA). Cells were incubated at 37 o C in 5% CO 2 in a humidified atmosphere. All test concentrations of armefolin showed no significant toxicity. The cell viability was determined by MTT assay.
Nitrite assay − RAW 264.7 cells (1 × 10 5 cells/mL in 48-well plate) were incubated for 20 h in the absence or presence of armefolin with LPS (1 μg/mL). NO was assessed by measuring the accumulated nitrite by Griess method. Briefly, samples (100 μL) of culture media were incubated with 150 μL of Griess reagent (1% sulfanilamide, 0.1% naphthylethylene diamine in 2.5% phosphoric acid solution) at room temperature for 10 min in a 96-well microplate. Absorbance at 540 nm was measured by using a microplate reader (Molecular Devices, CA, USA). The concentration of NO was determined by the sodium nitrite standard curve.
Western blot analysis − RAW 264. Reverse transcription and polymerase chain reaction (RT-PCR) − RAW 264.7 cells (5 × 10 5 cells/ 60 mm dish) were stimulated for 6 h with LPS (1 μg/mL) in the absence or presence of armefolin. Total RNA was isolated by TRIzol (Life technologies, Frederick, MD, USA) extraction according to the manufacturer's instructions, and then reverse transcribed into cDNA using reverse transcriptase (Life technologies, Frederick, MD, USA) and random hexamer (Cosmo, Seoul, Korea). Then PCR analyses were performed on the aliquots of cDNA preparations to detect gene expression of iNOS, IL-1β, IL-6, and β-actin using a recombinant Taq polymerase (Promega, Madison, WI, USA).
Statistical analysis − The results were expressed as mean ± S.D. of three experiments, and statistical analysis was performed by one way ANOVA and Student's t-test. A p value of < 0.05 was considered to indicate a significant difference.
Result and Discussion
The activity-guided purification of diethyl ether soluble fractions from the methanolic extract of A. iwayomogi was performed and led to the isolation of an active compound 1 (Fig. 1. A) . The structure of compound 1 was determined on the basis of spectroscopic analysis and by comparison with previous data.
17 Compound 1 was identified as naphtho [1,2-b] furan-2(3H)-one, 3a,4,5,5a,6, 7,8,9b-octahydro-6,8-dihydroxy-5a,9-dimethyl-3-methylene-, (3aS, 5aR,6R,8R,9bS)-, and named as armefolin. 17 This compound was isolated from A. iwayomogi for the first time.
The armefolin was examined the inhibitory effects on NO production in LPS-activated macrophages. As shown in Fig. 1.B ., armefolin concentration-dependently reduced NO production while LPS induced excessive NO production. In addition, cell viability was not affected by armefolin.
Next, we examined the effect of armefolin on the expression of iNOS, an enzyme for NO production in inflammatory response. Armefolin attenuated the expression of iNOS protein levels, whereas LPS treatment markedly up-regulated the protein level of iNOS in RAW 264.7 cells (Fig. 2.A) . Moreover, RT-PCR analysis showed down-regulation of mRNA level of iNOS by the treatment with armefolin in Fig. 2 .B. These results indicate that armefolin regulates the expressions of LPS-induced iNOS at the transcriptional level.
To examine the the suppressive potential of armefolin on pro-inflammatory cytokines, we investigated its effect on the levels of IL-1β and IL-6 mRNA expression in LPS-treated RAW 264.7 cells. As shown in Fig. 2 .B., armefolin down-regulated the IL-1β and IL-6 mRNA levels in a dose dependent manner. Taken together, these data suggest that armefolin, a sesquiterpene from A. iwayomogi has the anti-inflammatory potential by suppression of NO production through down-regulation of iNOS expression, and by inhibition of IL-1β and IL-6 expression in activated macrophage cells.
To reveal the molecular mechanism for the suppression of LPS-induced iNOS, IL-1β and IL-6 expressions by armefolin, we examined whether the armefolin affect the LPS-induced inhibitor κBα (I-κBα) degradation. I-κBα is located in cytoplasm as an active form that is physically binds with nuclear factor κB (NF-κB). NF-κB is an important transcription factor directing the expression of pro-inflammatory enzymes and cytokines such as iNOS, IL-1β and IL-6. 18 In response to stimuli such as LPS, I-κBα is phosphorylated, ubiquitinated, and rapidly degraded to release the NF-κB. 19 The free NF-κB moves to the nucleus and induces the expression of inflammatory genes. 20 As shown in Fig. 3 .A., armefolin concentrationdependently suppressed the LPS-induced degradation of I-κBα. These results suggest that armefolin from A. iwayomogi stabilize I-κBα, which results in suppression of the nuclear translocation and activation of NF-κB.
We also examined whether the armefolin could affect the mitogen-activated protein kinases (MAPKs) such as p38, JNK and ERK, because MAPKs are involved in the stabilization of I-κBα to activate NF-κB pathway. 21 It has been also reported that MAPK family proteins regulate inflammatory mediators such as NO and pro-inflammatory cytokines. 22, 23 To investigate the effect of armefolin on the LPS-induced activation of MAPK family proteins, we assessed the levels of phosphorylated p38, JNK and ERK in LPS-activated RAW 264.7 cells. As shown in Fig. 3 .B., armefolin did not affect the LPS-induced phosphorylation of p38, JNK and ERK, which suggests that suppression of LPS-induced I-κBα degradation by armefolin is not associated with p38, JNK and ERK activation. Aremfolin might regulate different pathway than p38, JNK and ERK to inhibit the expression of iNOS and inflammatory cytokines.
Taken together, armefolin from A. iwayomogi significantly suppressed the production of inflammatory mediator such as NO by suppressing the iNOS mRNA expression. This activity of armefolin was exhibited by inhibiting NF-κB pathway via suppression of I-κBα degradation in LPSactivated macrophages. The active sesquiterpene, armefolin, from A. iwayomogi may be a beneficial candidate for the treatment of inflammatory diseases accompanying the overproduction of NO. 
